Reversal of cachexia in patients treated with potent antiretroviral therapy.

D. Scevola(Policlinico San Matteo Fondazione), A. Faga(Fondazione Salvatore Maugeri), G. M. Minoia(University of Pavia), Andrea Di Matteo(Marche Polytechnic University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), F Poletti(University of Pavia)

PubMed

June 1, 2000

Cited by 21

Related Papers

Rheumatoid arthritis

|The Lancet|2023|731

Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy

|The Journal of Infectious Diseases|2001|173

Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

|New England Journal of Medicine|2001|168

Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

|Annals of Internal Medicine|2002|136

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

|Journal of Hepatology|2018|133